equityflowunderstand the flow and follow it
EquityFlow › Companies › Brenus Pharma

Brenus Pharma

Biotech · Lyon, FR

Cancer vaccine developer.

In the network

Shares the most investors with (number = shared investors):
DeuterOncology 2Myocene 2Sunrise Group 2

Funding history

DateRoundAmount
Jul 2026Series A
Lyon biotech Brenus Pharma raised an 11 million euro Series A extension from existing backers plus new investors Sambrinvest and Korea Omega Investment Corp. The funds complete its Phase I program and advance lead candidate STC-1010 for metastatic colorectal cancer.
$12.6M
Sep 2024Series A
Lyon biotech Brenus Pharma raised a €22.2M Series A led by Angelor to fund its first cancer-vaccine clinical trial.
$24M

Investors

Tap an investor to see what else they have backed.

AngelorBIO JAGBpifranceCrédit AgricoleInvestsud TechKorea Omega Investment CorpNOSHAQOrsaSambrinvestUI Investissement

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in FR

CardNexusMendoUncovrAlta AresInnovafeedInnovorderQuoblyMokNWandercraftArlequin AIKoletFungu'it

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.